MOREPENLAB — Morepen Laboratories Share News
0.000.00%
- IN₹67.69bn
- IN₹69.24bn
- IN₹18.06bn
India's Morepen jumps as FDA clears API manufacturing facility
Brief: Morepen Laboratories Incorporates Unit Morepen Rx
India's Morepen Laboratories slips on lower Q3 profit
India's Morepen Labs falls nearly 10% after block deals
NSEI Block Deal MOREPEN LAB 690,230 shares at 47.30 INR
Brief: India's Morepen Laboratories June-Quarter Consol Net Profit Falls
Brief: Morepen Laboratories Dec-Qtr Consol Net Profit Falls
India's Morepen Labs jumps on U.S. FDA nod for Allegra generic
Brief: Morepen Laboratories Says Received USFDA Approval For Anti-Allergy Drug Fexofinadine Hydrochloride
India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal
Brief: Morepen Laboratories Sept-Quarter Consol Net Profit Rises
Brief: Morepen Labs Carves Out Point Of Care Medical Devices Business Into New Unit, Morepen Devices
Approved Transfer Of Medical Devices Business On A Slump Sale Basis
Brief: Morepen Laboratories Ltd June Quarter Consol Net Profit Rises
Indian shares end lower as Tata Motors warns of chip shortage hit at JLR
Brief: Morepen Laboratories - RDIF, Co Announce Production Of Test Batch Of Sputnik V In India
Morepen Labs hits near 19-1/2-yr high on first test batch of Sputnik V vaccine
India's Morepen makes first test batch of Russia's Sputnik V shot - fund
Brief: Morepen Labs Reports Higher March-Quarter Profit